Angiogenesis and VEGF in Cancer
Angiogenesis and VEGF in Cancer is a research topic within Molecular Biology. Science Explorer counts 38k research works in it since 1950. 19.9% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the molecular mechanisms of angiogenesis, including the role of VEGF, endothelial progenitor cells, pericytes, and anti-angiogenic therapy in regulating tumor vasculature and vascular function. It explores the signaling pathways, therapeutic targets, and clinical applications related to angiogenesis.
- VEGF
- endothelial progenitor cells
- tumor angiogenesis
- anti-angiogenic therapy
- vascular endothelial growth factor
- pericytes
- vascular normalization
- endothelial cell behavior
- tumor vasculature
- angiogenic signaling
- Research works
- 38k fractional, since 1950
- In the world top 10%
- 7.6k per year above
- Top-10% rate
- 19.9% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- -26% the tick is no change
Which countries lead Angiogenesis and VEGF in Cancer research?
By volume, China and the United States publish the most (1.1k and 748 works in 2022–2025).
By volume, 2022–2025
- 1 China 1.1k works
- 2 United States 748 works
- 3 Japan 193 works
- 4 Germany 156 works
- 5 Italy 126 works
- 6 India 116 works
- 7 United Kingdom 114 works
- 8 South Korea 105 works
- 9 France 78 works
- 10 Russia 74 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Angiogenesis and VEGF in Cancer research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Angiogenesis and VEGF in Cancer research, followed by University of Bari Aldo Moro and Sun Yat-sen University.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 20 works
- 2 University of Bari Aldo MoroItaly 20 works
- 3 Sun Yat-sen UniversityChina 19 works
- 4 University of North Carolina at Chapel HillUnited States 17 works
- 5 Sichuan UniversityChina 14 works
- 6 Harvard UniversityUnited States 13 works
- 7 Shanghai Jiao Tong UniversityChina 13 works
- 8 Nanjing Medical UniversityChina 13 works
- 9 Huazhong University of Science and TechnologyChina 11 works
- 10 Yale UniversityUnited States 10 works
Who are the leading researchers in Angiogenesis and VEGF in Cancer?
The most-cited researchers publishing on Angiogenesis and VEGF in Cancer include Dirk Schadendorf.
- 1 Dirk Schadendorf Germany 4.4k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Angiogenesis and VEGF in Cancer research done?
The largest centres of Angiogenesis and VEGF in Cancer research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Bari.
Largest cities, 2022–2025
Where it is the local speciality
- BariIT · 22.2 works11×
Location quotient: how much more of its research is in Angiogenesis and VEGF in Cancer than the world average.
Where is the best place to study Angiogenesis and VEGF in Cancer?
Among universities, judged by research, University of Bari Aldo Moro, Xuzhou Medical College and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | University of Bari Aldo MoroItaly | 58.2 | 10.2% | 17.8× | 20 | -29.7% |
| 2 | Xuzhou Medical CollegeChina | 56.1 | 18.6% | 13.2× | 10 | +29.9% |
| 3 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 52.7 | 20.7% | 6.0× | 20 | -31.7% |
| 4 | Sun Yat-sen UniversityChina | 51.6 | 25.1% | 3.4× | 19 | -14.6% |
| 5 | Yale UniversityUnited States | 46.2 | 38.7% | 3.0× | 10 | -41.0% |
| 6 | Wenzhou Medical UniversityChina | 45.1 | 18.2% | 7.6× | 9 | +13.2% |
| 7 | China Medical UniversityChina | 44.0 | 32.4% | 7.5× | 9 | -57.7% |
| 8 | Sichuan UniversityChina | 40.9 | 28.3% | 2.2× | 14 | -23.0% |
| 9 | Huazhong University of Science and TechnologyChina | 40.2 | 33.1% | 1.9× | 10 | -15.1% |
| 10 | Nanjing Medical UniversityChina | 39.3 | 17.0% | 7.0× | 12 | -39.4% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Angiogenesis and VEGF in Cancer research growing?
Output in 2018–2022 was 26% lower than in 2013–2017, peaking in 2012.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.